1-3 of 3
Kemal Caglar Gogebakan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling

Free
Jane M. Lange, Kemal Caglar Gogebakan, Roman Gulati, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2024) 33 (6): 830–837.
https://doi.org/10.1158/1055-9965.EPI-23-1470
Published: 03 June 2024
View articletitled, Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling
Open the PDF for Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling in another window
Includes: Supplementary data
Journal Articles

Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Available to Purchase
Lukas Owens, Kemal Caglar Gogebakan, Usha Menon, Roman Gulati, Noel S. Weiss, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2023) 32 (6): 741–743.
https://doi.org/10.1158/1055-9965.EPI-22-1307
Published: 01 June 2023
View articletitled, Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?
Open the PDF for Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter? in another window
Journal Articles

Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach

Available to Purchase
Kemal Caglar Gogebakan, Elizabeth G. Berry, Alan C. Geller, Kemal Sonmez, Sancy A. Leachman, Ruth Etzioni
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2020) 29 (12): 2599–2607.
https://doi.org/10.1158/1055-9965.EPI-20-0881
Published: 01 December 2020
View articletitled, Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach
Open the PDF for Strategizing Screening for Melanoma in an Era of Novel Treatments: A Model-Based Approach in another window
Includes: Supplementary data